Log in

Relevant bibliographies by topics / Byar / Journal articles

To see the other types of publications on this topic, follow the link: Byar.

Journal articles on the topic 'Byar'

Author: Grafiati

Published: 4 June 2021

Last updated: 1 August 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Byar.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Green, Sylvan B. "David Byar: An accidental career." Controlled Clinical Trials 16, no. 4 (1995): 189–90. http://dx.doi.org/10.1016/s0197-2456(95)80002-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Greenhouse, Samuel W. "Dave Byar as a student." Controlled Clinical Trials 16, no. 4 (1995): 191–92. http://dx.doi.org/10.1016/s0197-2456(95)80003-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Schneiderman, Marvin A. "David Byar as a supervisee." Controlled Clinical Trials 16, no. 4 (1995): 193–96. http://dx.doi.org/10.1016/s0197-2456(95)80004-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Mantel, Nathan. "David Byar as a collaborator." Controlled Clinical Trials 16, no. 4 (1995): 197–201. http://dx.doi.org/10.1016/s0197-2456(95)80005-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Piantadosi, Steven. "David Byar as a teacher." Controlled Clinical Trials 16, no. 4 (1995): 202–11. http://dx.doi.org/10.1016/s0197-2456(95)80006-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Freedman, Laurence S. "Obituary: David Peery Byar (1938-91)." Journal of the Royal Statistical Society: Series A (Statistics in Society) 155, no. 3 (1992): 464–65. http://dx.doi.org/10.1111/j.1467-985x.1992.tb00388.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Aas, Steinar. "Finst det byar i Nord-Noreg?" Septentrio Conference Series, no. 2 (November 30, 2023): 77–86. http://dx.doi.org/10.7557/5.7309.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Valeri, S., R. Tonini, and G. Ottaviani. "Auger-electron emission induced byAr+impact on silicides." Physical Review B 38, no. 18 (1988): 13282–90. http://dx.doi.org/10.1103/physrevb.38.13282.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Harrington, Mark. "In memoriam: David Byar as an AIDS activist." Controlled Clinical Trials 16, no. 4 (1995): 270–75. http://dx.doi.org/10.1016/s0197-2456(95)80012-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Tjelmeland, Hallvard. "Finst det byar i Nord-Noreg – ein kommentar." Septentrio Conference Series, no. 2 (November 30, 2023): 87–89. http://dx.doi.org/10.7557/5.7310.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Valeri, S., M. Liberi, and R. Verucchi. "PLVVandLMMAuger emission induced byAr+impact on the InP(110) surface." Physical Review B 56, no. 23 (1997): 15272–76. http://dx.doi.org/10.1103/physrevb.56.15272.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Oh, Sera, A. Rheum Han, Hye Ryeon Park, et al. "Suppression of Inflammatory Cytokine Production byar-Turmerone Isolated fromCurcuma phaeocaulis." Chemistry & Biodiversity 11, no. 7 (2014): 1034–41. http://dx.doi.org/10.1002/cbdv.201300397.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Akbari, Saeeid, Abbas Alilou, Jafar Amjadi, and Seyed Mahmoud Sheikholeslami. "The Co-annihilating-ideal Graphs of Commutative Rings." Canadian Mathematical Bulletin 60, no. 1 (2017): 3–11. http://dx.doi.org/10.4153/cmb-2016-017-1.

Full text

Abstract:

AbstractLetRbe a commutative ring with identity. The co-annihilating-ideal graph ofR, denoted byAR, is a graph whose vertex set is the set of all non-zero proper ideals ofRand two distinct verticesIandJare adjacent whenever Ann(I) ∩ Ann(J) = {0}. In this paper we initiate the study of the co-annihilating ideal graph of a commutative ring and we investigate its properties.

APA, Harvard, Vancouver, ISO, and other styles

14

Dwipayana, Kadek, I. Made Agus Wirawan, and I. Gede Partha Sindu. "Go-Byar Based on Virtual Reality for the Learning Media of Gamelan." Jurnal Pendidikan Teknologi dan Kejuruan 25, no. 2 (2019): 229–36. http://dx.doi.org/10.21831/jptk.v25i2.26182.

Full text

Abstract:

Gong Kebyar is one of the group of Balinese music that has five pelog tones which the playing technique using kebyar system. Gong Kebyar serves the instrumental performances, accompanying various types of dances, and accompanying Himdu's religious ceremonial activities in Bali. But not many young people can play the gong kebyar due to lack of adequate facilities. One effort that can be done is to utilize virtual reality technology as an instructional media for playing Gong Kebyar. The purpose of the study was to design and implement the design of Gamelan Gong Kebyar based on Virtual Reality.Th

APA, Harvard, Vancouver, ISO, and other styles

15

Larson, S. A., and L. L. Lauderback. "Azimuthal-angle and energy distributions ofAl2+ejected from Al(100) byAr+bombardment." Physical Review B 43, no. 1 (1991): 36–42. http://dx.doi.org/10.1103/physrevb.43.36.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Russell, Nigel H., Andrew J. Howman, Keith Wheatley, et al. "Outcome of Reduced Intensity Allografts in Patients Aged Over 45 Years with Acute Myeloid Leukaemia: Initial Results of the MRC AML15 Trial." Blood 114, no. 22 (2009): 523. http://dx.doi.org/10.1182/blood.v114.22.523.523.

Full text

Abstract:

Abstract Abstract 523 Introduction: The advent of reduced intensity conditioning (RIC) regimens permits the delivery of allogeneic stem cell transplant (alloSCT) with a potentially curative graft-versus-leukaemia effect in patients with acute myeloid leukaemia (AML) whose outcome with conventional chemotherapy or conventional myeloablative SCT would be poor. Although widely utilised in the management of older patients with AML in 1st complete remission (CR) there are no randomised trials or “donor v. no donor” analyses supporting a role for RIC alloSCT in this setting. Methods: We have examine

APA, Harvard, Vancouver, ISO, and other styles

17

Burnett, Alan K., Anthony Goldstone, Robert K. Hills, et al. "Curability of Patients With Acute Myeloid Leukemia Who Did Not Undergo Transplantation in First Remission." Journal of Clinical Oncology 31, no. 10 (2013): 1293–301. http://dx.doi.org/10.1200/jco.2011.40.5977.

Full text

Abstract:

Purpose The aims of this study were to quantify the prospects of salvage treatment of patients who did not undergo transplantation in first complete remission (CR1) and to assess the contribution of allograft in second complete remission (CR2) with respect to major risk groups. This evaluation can inform the decision whether to offer a transplant in CR1. Patients and Methods Of 8,909 patients who entered the Medical Research Council AML10, AML12, and AML15 trials, 1,271 of 3,919 patients age 16 to 49 years who did not receive a transplant in CR1 relapsed. Of these patients, 19% are alive beyon

APA, Harvard, Vancouver, ISO, and other styles

18

Schrauder, André, Alfred Reiter, Helmut Gadner, et al. "Superiority of Allogeneic Hematopoietic Stem-Cell Transplantation Compared With Chemotherapy Alone in High-Risk Childhood T-Cell Acute Lymphoblastic Leukemia: Results From ALL-BFM 90 and 95." Journal of Clinical Oncology 24, no. 36 (2006): 5742–49. http://dx.doi.org/10.1200/jco.2006.06.2679.

Full text

Abstract:

Purpose The role of hematopoietic stem-cell transplantation (SCT) in first complete remission (CR1) for children with very high–risk (VHR) acute lymphoblastic leukemia (ALL) is still under critical discussion. Patients and Methods In the ALL–Berlin-Frankfurt-Münster (BFM) 90 and ALL-BFM 95 trials, 387 patients were eligible for SCT if there was a matched sibling donor (MSD). T-cell ALL (T-ALL) patients with poor in vivo response to initial treatment represented the largest homogeneous subgroup within VHR patients. Results Of 191 high-risk (HR) T-ALL patients, 179 patients (94%) achieved CR1. T

APA, Harvard, Vancouver, ISO, and other styles

19

Lee, Hyung-Ik, Ryuichi Shimizu, Masahiko Inoue, Kazuo Kajiwara, and Siegfried Hofmann. "Monte Carlo Simulation for Auger Depth Profiling of GaAs/AlAs Superlattice Structure byAr+Ion Sputtering." Japanese Journal of Applied Physics 35, Part 1, No. 4A (1996): 2271–74. http://dx.doi.org/10.1143/jjap.35.2271.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Granqvist, Raoul J. "Erla Husgafvel, österbottnisk folklorist i två länder." Budkavlen 93 (May 19, 2023): 86–100. http://dx.doi.org/10.37447/bk.129712.

Full text

Abstract:

Liksom Linnés lärjungar, och Ngugis studenter två hundra år senare, hade etnologer vid 1920- och 1930-talens Åbo Akademi påbörjat insamlingar om lokala seder och språkbruk -- även de med en engagerad kulturinstitutions, Svenska Litteratursällskapet, lika beskäftiga instruktionshäfte i handen. En av de mest hängivna var Erla Hovilainen-Husgafvel (f. Lund) som under åren 1928–1939 gjorde tio fältexpeditioner till aderton byar i Österbotten (dessutom en till Estland) i jakt på en kunskap alltmer undanträngd av aktiv och passiv glömska eller avståndstagande. I Erlas fall innehöll kunskapen folktro

APA, Harvard, Vancouver, ISO, and other styles

21

van Veen, G. N. A., F. H. M. Sanders, J. Dieleman, A. van Veen, D. J. Oostra, and A. E. de Vries. "Anomalous Time-of-Flight Distributions Observed for Argon Implanted in Silicon and Resputtered byAr+-Ion Bombardment." Physical Review Letters 57, no. 6 (1986): 739–42. http://dx.doi.org/10.1103/physrevlett.57.739.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Sayyed, Ayman, Taehyung Simon Kim, Silvia Park, et al. "Is Allogeneic Hematopoietic Stem Cell Transplant (HCT) in First Remission Beneficial to Acute Myeloid Leukemia (AML) Patients with Isocitrate Dehydrogenase(IDH) Mutations?" Blood 142, Supplement 1 (2023): 4960. http://dx.doi.org/10.1182/blood-2023-191113.

Full text

Abstract:

Introduction Somatic mutations in the isocitrate dehydrogenase 1 and 2 genes (IDH1 and IDH2) are relatively frequent in acute myeloid leukemia (AML) but with heterogeneous prognoses. The prognostic impact of this AML subtype with IDH mutations may be influenced by the comutational status with other somatic mutation, the specific types of IDH1/2 mutation (ie, IDH1 R132, IDH2 R140, and IDH2 R172). Allogeneic stem cell transplant allogeneic HCT represents a curative option for subgroups of AML patients (pts), but not for all subtypes. Transplant referral is made based on the ELN risk group classi

APA, Harvard, Vancouver, ISO, and other styles

23

Lauderback, L. L., Y. Zhang, and R. Nge. "Effect of surface thermal vibrations on the azimuthal-angle distribution ofNi+ejected from Ni(111) byAr+bombardment." Physical Review B 48, no. 3 (1993): 1750–56. http://dx.doi.org/10.1103/physrevb.48.1750.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Pérez Alcázar, Germán A., Ligia Edith Zamora, José Francisco Marco, Juan José Romero, Jesús María González, and Francisco Javier Palomares. "Magnetic and Structural Characterization of Mechanically Alloyed Fe50co50 Samples." Revista de Ciencias 15 (February 13, 2012): 41–47. http://dx.doi.org/10.25100/rc.v15i0.516.

Full text

Abstract:

Samples of nominal composition Fe50Co50 were produced by mechanical alloying byusing a planetary ball mill and different milling times. The samples were studied via X-raydiffraction, Mössbauer spectroscopy, and X-ray photoelectron spectroscopy to characterize thephase distribution resulting from the milling process. The Mössbauer data indicated that Co startsdiffusing into Fe after 8 h of milling. Between t = 8h and t = 24 h the sample has a heterogeneouscomposition, presenting a bimodal hyperfine field distribution with maxima centred at 34.3 T and35.8 - 36.4 T, compatible with the presence o

APA, Harvard, Vancouver, ISO, and other styles

25

Ulmillah, Aulia, Dwijowati Asih Saputri, Ika Listiana, and Karina Karina. "Pemanfaatan Tanaman Pisang (Musa spp.): Analisis Jenis, Organ Tanaman, Dan Aplikasi Dalam Bidang Pangan, Budaya, Dan Pertanian." Jurnal Penelitian Sains dan Pendidikan (JPSP) 4, no. 1 (2024): 57–69. http://dx.doi.org/10.23971/jpsp.v4i1.7915.

Full text

Abstract:

Masyarakat secara luas memanfaatkan tanaman pisang (Musa spp.) dalam kehidupan sehari-hari mereka. Penelitian ini dilakukan untuk mengidentifikasi jenis-jenis tanaman pisang yang berbeda, organ tanaman yang digunakan dan aplikasinya dalam bidang pangan, budaya, dan pertanian. Metode penelitian yang digunakan adalah kualitatif, dan sampel dikumpulkan melalui teknik purposive sampling dengan kelompok informan terdiri dari 2 tokoh adat, 2 penjual pisang sebagai informan kunci, 25 warga masyarakat Desa Makarti sebagai informan utama, dan satu tokoh masyarakat sebagai informan tambahan.dan snowball

APA, Harvard, Vancouver, ISO, and other styles

26

Diaz-Beya, Marina, Miguel Angel Torrente, Alfonso Ardilla, et al. "Feasibility and Outcome of Allogeneic Hematopoietic Stem-Cell Transplantation in High-Risk AML: Real-Life Perspective from a Single Institution." Blood 126, no. 23 (2015): 4395. http://dx.doi.org/10.1182/blood.v126.23.4395.4395.

Full text

Abstract:

Abstract Introduction: Allogeneic stem cell transplant (alloHSCT) is the treatment of choice in patients with high-risk acute myeloid leukemia (AML). However, it is uncertain exactly how many of these patients actually undergo alloHSCT as planned initially. Moreover, the real efficacy of this therapeutic option remains controversial. Since few studies have addressed these questions, to shed light on these issues, we have analyzed the results of a policy of early donor search, the proportion of patients in which initially planned alloHSCT was performed, and the outcome of alloHSCT in our center

APA, Harvard, Vancouver, ISO, and other styles

27

Dhédin, Nathalie, Anne Huynh, Sébastien Maury, et al. "Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) In Adults With Philadelphia Chromosome (Ph)-Negative Acute Lymphoblastic Leukemia (ALL): Results From The Group For Research On Adult ALL (GRAALL)." Blood 122, no. 21 (2013): 552. http://dx.doi.org/10.1182/blood.v122.21.552.552.

Full text

Abstract:

Abstract Purpose The pediatric-inspired intensified GRAALL protocol yielded a marked improvement in the outcome of adults with Ph-negative acute lymphoblastic leukemia (ALL) (Huguet et al,JCO 2009), raising the issue of the place of allogeneic HSCT in this new context. We report here the results associated with HSCT in first complete remission (CR) in younger adults treated in the GRAALL-2003/2005 trials. Patients and methods In these trials, HSCT was offered in first CR to patients aged 15-55 years with ALL at higher risk of relapse. High-risk factors included white blood count >30 x 109/L

APA, Harvard, Vancouver, ISO, and other styles

28

Sayyed, Ayman, Taehyung Simon Kim, Silvia Park, et al. "Acute Myeloid Leukemia (AML) Patients with Myelodysplasia (MDS) Related-Gene Mutations in First Complete Remission (CR1) Found to Have Benefit from Allogeneic Hematopoietic Stem Cell Transplant (HCT)." Blood 142, Supplement 1 (2023): 4954. http://dx.doi.org/10.1182/blood-2023-191011.

Full text

Abstract:

Introduction: Acute myeloid leukemia (AML) with myelodysplasia-related gene mutations is a new disease entity introduced in the International Consensus Classification of Myeloid Neoplasms 2022 (ICC 2022). Myelodysplasia-related gene mutations include ASXL1, BCOR, EZH2, RUNX1, SF3B1, SRSF2, STAG2, U2AF1, or ZRSR2 . Allogeneic hematopoietic stem cell transplant (HCT) represents a curative option for subgroups of AML patients, but not for all. In a prior study (Song et al.) reported the survival benefit of allogeneic HCT in 59 patients with AML with secondary type mutations (STM) including SRSF2,

APA, Harvard, Vancouver, ISO, and other styles

29

Delaplace, Gregory, and P. Chuluunbat. "When the Picture Comes in." Inner Asia 24, no. 1 (2022): 103–30. http://dx.doi.org/10.1163/22105018-02302019.

Full text

Abstract:

Abstract This article sketches out the conditions in which winning (türüüleh) may be achieved in Mongolian wrestling tournaments. Fieldwork carried out before, during and after the yearly competition of Naadam in the summer of 2019 suggests that these conditions are indeed rather diverse in nature. Getting ready for a contest requires wrestlers to be tending to several aspects of their personhood, as their strength, power (byar) or the success of their techniques (meh) depend not only on their physical preparedness, but also on a delicate balancing of social, technical and cosmological skills.

APA, Harvard, Vancouver, ISO, and other styles

30

Kudo, Masatoshi, Kazuomi Ueshima, Chikara Ogawa, and Yasutaka Chiba. "Objective response (OR) by mRECIST to predict overall survival (OS) in patients with hepatocellular carcinoma (HCC) treated with sorafenib in the SILIUS trial." Journal of Clinical Oncology 38, no. 4_suppl (2020): 534. http://dx.doi.org/10.1200/jco.2020.38.4_suppl.534.

Full text

Abstract:

534 Background: In SILIUS (NCT01214343) trial, combination of sorafenib and hepatic arterial infusion chemotherapy did not significantly improve OS in patients with advanced HCC compared with sorafenib alone (Kudo M, et al. Lancet Gastroenterol Hepatol 2018). In this study, we explored the relationship between OR and OS in the sorafenib group in the SILIUS trial. Methods: Association between OR and OS in patients treated with sorafenib ( n = 103) were analyzed. The median OS of responders was compared with that of non-responders by using Mantel-Byar test to exclude guarantee-time bias. Landmar

APA, Harvard, Vancouver, ISO, and other styles

31

Kok, Victor, Yu-Ching Chen, Yang-Yuan Chen, et al. "Sorafenib with Transarterial Chemoembolization Achieves Improved Survival vs. Sorafenib Alone in Advanced Hepatocellular Carcinoma: A Nationwide Population-Based Cohort Study." Cancers 11, no. 7 (2019): 985. http://dx.doi.org/10.3390/cancers11070985.

Full text

Abstract:

We hypothesized that sorafenib plus transarterial chemoembolization (TACE) would confer survival benefits over sorafenib alone for advanced hepatocellular carcinoma (aHCC). We investigated this while using the population-based All-Cancer Dataset to assemble a cohort (n = 3674; median age, 60; 83% men) of patients receiving sorafenib for aHCC (Child-Pugh A) with macro-vascular invasion or nodal/distant metastases. The patients were classified into the sorafenib-TACE group (n = 426) or the propensity score-matched sorafenib-alone group (n = 1686). All of the participants were followed up until d

APA, Harvard, Vancouver, ISO, and other styles

32

Reinhardt, Dirk, Bernhard Kremens, Martin Zimmermann, et al. "No Improvement of Overall-Survival in Children with High-Risk Acute Myeloid Leukemia by Stem Cell Transplantation in 1st Complete Remission." Blood 108, no. 11 (2006): 320. http://dx.doi.org/10.1182/blood.v108.11.320.320.

Full text

Abstract:

Abstract One aim of the AML-BFM 98 study was to evaluate prospectively the impact of matched sibling donor (MSD)-SCT in 1st complete remission (CR) in children with high-risk (HR)-AML. Patients: Between 7/1998 and 3/2004 494 children and adolescents were enrolled in the studies AML-BFM 98 and the AML-BFM 98 Interim 2003. Patients with favorable cytogenetics [t(8;21), inv(16), t(15;17)], corresponding morphology (AML FAB M1/2 with Auer rods, M4eo, M3) and < 5% blasts on day 15 were defined as standard risk (SR)-group (n=177). All others were stratified to HR-group (n=317) and eligible for SC

APA, Harvard, Vancouver, ISO, and other styles

33

Sule, George I., Angela U. Chukwu, and Felix C. Akanno. "Accelerated failure time survival model for prostate cancer." International Journal Of Community Medicine And Public Health 10, no. 10 (2023): 3459–64. http://dx.doi.org/10.18203/2394-6040.ijcmph20233069.

Full text

Abstract:

Background: Prostate cancer is the second most common cancer in men globally and ranks sixth among male cancer-related deaths. This study utilized survival analysis to assess post-diagnosis outcomes, aiming to enhance prostate cancer patient longevity. Insights were gained by determining median survival times, identifying prognostic factors, and applying an AFT model to prostate cancer data. Methods: The study collected data from 502 prostate cancer patients featured in a 1980 paper by D. P. Byar and S. B. Green, focusing on stage 3 or 4 cases. Over six years, they monitored these patients' su

APA, Harvard, Vancouver, ISO, and other styles

34

Rambaldi, Alessandro, Francoise Huguet, Pavel Zak, et al. "Blinatumomab consolidation and maintenance therapy in adults with relapsed/refractory B-precursor acute lymphoblastic leukemia." Blood Advances 4, no. 7 (2020): 1518–25. http://dx.doi.org/10.1182/bloodadvances.2019000874.

Full text

Abstract:

Abstract In a phase 3 clinical study of heavily pretreated adults with relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL), overall survival (OS) following blinatumomab, a BiTE (bispecific T-cell engager) immunooncology therapy, was significantly improved vs chemotherapy following induction (cycles 1 to 2). Here we report the efficacy and safety of those who received additional cycles of blinatumomab. Blinatumomab was administered as a continuous IV infusion for 4 weeks in a 6-week cycle. Patients who achieved a bone marrow response (≤5% blasts) or complete remission (full, partial, o

APA, Harvard, Vancouver, ISO, and other styles

35

Gröschel, Stefan, Richard F. Schlenk, Jan Engelmann, et al. "Deregulated Expression of EVI1 Defines a Poor Prognostic Subset of MLL-Rearranged Acute Myeloid Leukemias: A Study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group." Journal of Clinical Oncology 31, no. 1 (2013): 95–103. http://dx.doi.org/10.1200/jco.2011.41.5505.

Full text

Abstract:

Purpose To evaluate the prognostic value of ecotropic viral integration 1 gene (EVI1) overexpression in acute myeloid leukemia (AML) with MLL gene rearrangements. Patients and Methods We identified 286 patients with AML with t(11q23) enrolled onto German-Austrian Acute Myeloid Leukemia Study Group and Dutch-Belgian-Swiss Hemato-Oncology Cooperative Group prospective treatment trials. Material was available from 177 AML patients for EVI1 expression analysis. Results We divided 286 MLL-rearranged AMLs into three subgroups: t(9;11)(p22;q23) (44.8%), t(6;11)(q27;q23) (14.7%), and t(v;11q23) (40.5%

APA, Harvard, Vancouver, ISO, and other styles

36

Hospital, Marie-Anne, Xavier Thomas, Sylvie Castaigne, et al. "Long-Term Outcome Associated with Current Allogeneic Stem Cell Transplantation Procedures In Younger Adults with Adverse-Risk AML In First CR – A Real-Life Transplant Versus No-Transplant Analysis of the Acute Leukemia French Association (ALFA)." Blood 116, no. 21 (2010): 3513. http://dx.doi.org/10.1182/blood.v116.21.3513.3513.

Full text

Abstract:

Abstract Abstract 3513 Purpose: Based on donor versus no-donor studies, allogeneic stem cell transplantation (SCT) is the best treatment option for younger patients with intermediate- or adverse-risk AML in first CR (Cornelissen et al. Blood 2007; Koreth et al. JAMA 2009). However, in these intent-to-treat studies, the benefit associated with SCT seems often small in the adverse-risk subgroup, probably due to a higher incidence of early relapse. In addition, the definition of the donor group has evolved with the increasing use of alternative SC sources. To assess the role of current SCT proced

APA, Harvard, Vancouver, ISO, and other styles

37

Hussein, Naser S., Shapiee B. Samat, Mohd Abdullah, and Mohd N. Gohar. "Objective Scoring Evaluation and Uroflowmetry Assessment of Two-Stage Hypospadias Repair: Single Center Experience." Bangladesh Journal of Medical Science 12, no. 2 (2013): 133–39. http://dx.doi.org/10.3329/bjms.v12i2.14940.

Full text

Abstract:

Background: Hypospadias is a common congenital anomaly affecting the penis, two-stage repair becoming more interesting in era of tubularized incised urethral plate (TIP). Functional outcome of hypospadias repair either single or two stage is as important as cosmetic outcome. In contemporary series , structured scoring systems (Hypospadias Objective Scoring Evaluation-HOSE and Pediatric Penile Perception Scoring -PPPS), evaluation of photographs and uroflowmetry, were used to assess results of hypospadias repair. Objectives: We have assessed outcomes of two-stage hypospadias repair using Hypos

APA, Harvard, Vancouver, ISO, and other styles

38

Liberatore, Carmine, Maria Teresa Lupo Stanghellini, Francesca Lorentino, et al. "Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donors." Therapeutic Advances in Hematology 13 (January 2022): 204062072210908. http://dx.doi.org/10.1177/20406207221090882.

Full text

Abstract:

Introduction: Azacitidine (AZA) either single-agent or with donor lymphocytes infusions (DLI) has been used as a salvage treatment for acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) relapsing after allogeneic hematopoietic stem cell transplantation (HSCT). To date, the majority of data come from patients relapsed after HSCT from full-matched donors. Methods: We report a multicenter, collaborative, retrospective analysis of 71 patients with hematologic ( n = 40, 56%) and molecular relapse ( n = 31, 44%) of myeloid neoplasms after HSCT from alternative donors (mismatched unrela

APA, Harvard, Vancouver, ISO, and other styles

39

Hasle, Henrik, Todd Alonzo, Anne Avrignon, et al. "Monosomy 7 and Deletion 7q in Childhood AML. A Collaborative Study of 20 Study Groups." Blood 104, no. 11 (2004): 402. http://dx.doi.org/10.1182/blood.v104.11.402.402.

Full text

Abstract:

Abstract Monosomy 7 (−7) and deletion 7q [del(7q)] are rare in childhood AML and are considered to be associated with a poor outcome. We retrospectively analyzed data on 267 children with de novo AML or RAEB-T (PB or BM blasts > 20%) with −7 or del(7q) with or without additional cytogenetic aberrations (other). Patients were diagnosed between 1985 and 2003. Karyotypes showed −7 (n=90), −7 other (n=82), del(7q) (n=22), and del(7q) other (n=73). All 24 patients with RAEB-T had −7 +/− other. The median age at diagnosis was 7.6 years (range; 0–18.1) with no difference in age distribution betwee

APA, Harvard, Vancouver, ISO, and other styles

40

Vicentini, Costanza, Enrico Ricchizzi, Antonino Russotto, et al. "Validation of the prevalence to incidence conversion method for healthcare associated infections in long-term care facilities." PLOS ONE 19, no. 3 (2024): e0300794. http://dx.doi.org/10.1371/journal.pone.0300794.

Full text

Abstract:

Introduction Residents of long-term care facilities (LTCFs) are a population at high risk of developing severe healthcare associated infections (HAIs). In the assessment of HAIs in acute-care hospitals, selection bias can occur due to cases being over-represented: patients developing HAIs usually have longer lengths of stays compared to controls, and therefore have an increased probability of being sampled in PPS, leading to an overestimation of HAI prevalence. Our hypothesis was that in LTCFs, the opposite may occur: residents developing HAIs either may have a greater chance of being transfer

APA, Harvard, Vancouver, ISO, and other styles

41

Ferguson, Paul, Robert K. Hills, Angela Grech, et al. "An Operational Definition of Primary Refractory Acute Myeloid Leukaemia Which Allows Early Identification of Patients for Whom Allogeneic Stem Cell Transplantation Represents the Only Curative Therapy." Blood 126, no. 23 (2015): 559. http://dx.doi.org/10.1182/blood.v126.23.559.559.

Full text

Abstract:

Abstract Purpose Resistance to induction chemotherapy (IC) is an important adverse prognostic factor in adults with newly diagnosed acute myeloid leukaemia (AML), particularly older patients. Despite its therapeutic relevance there is however no universally agreed definition of primary refractory AML (PREF AML). Nor has the role of allogeneic stem cell transplantation (alloSCT) been defined in this clinical setting in a large patient cohort. To address these issues we examined long term outcomes in patients with refractory AML after IC, identified using three differing criteria. Patients and M

APA, Harvard, Vancouver, ISO, and other styles

42

Burnett, Alan K., Robert K. Hills, Anthony H. Goldstone, et al. "The Impact of Transplant in AML in 2nd CR: A Prospective Study of 741 in the MRC AML 10 and 12 Trials." Blood 104, no. 11 (2004): 620. http://dx.doi.org/10.1182/blood.v104.11.620.620.

Full text

Abstract:

Abstract MRC AML10 and 12 Trials recruited 5425 patients of whom 4557(84%) entered CR and were treated with chemotherapy only. 741 relapsed and achieved a second CR. These patients were recommended for salvage by stem cell transplantation either sibling or MUD allograft or autograft. In a non-randomised comparison, Mantel-Byar and delayed entry proportional hazards regression were used to investigate outcome and which factors were predictive for survival. Of the 741 patients in CR2 480 received a SCT (116 sib Allo: 192 Autograft and 154 MUD 18 other/unknown) at a median of 107 days from second

APA, Harvard, Vancouver, ISO, and other styles

43

Medalen, Tor. "Framtidens byer – byer med lave klimagassutslipp." Plan 41, no. 01 (2009): 8–13. http://dx.doi.org/10.18261/issn1504-3045-2009-01-03.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Nystad, Jens Fredrik. "Bærekraftige byer?" Plan 41, no. 01 (2009): 2. http://dx.doi.org/10.18261/issn1504-3045-2009-01-01.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Gjørven, Guro. "Krympende byer." Plan 47, no. 02 (2015): 32–37. http://dx.doi.org/10.18261/issn1504-3045-2015-02-07.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Nystad, Jens Fredrik. "Dynamiske byer." Plan 37, no. 02 (2005): 2. http://dx.doi.org/10.18261/issn1504-3045-2005-02-01.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Ekman, Ulrik. "Resiliente byer." Nordic Journal of Urban Studies 1, no. 2 (2021): 185–95. http://dx.doi.org/10.18261/issn.2703-8866-2021-02-06.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Burnett, Alan K., Robert K. Hills, Keith Wheatley, Anthony H. Goldstone, Archie G. Prentice, and Donald Milligan. "A Sensitive Risk Score for Directing Treatment in Younger Patients with AML." Blood 108, no. 11 (2006): 18. http://dx.doi.org/10.1182/blood.v108.11.18.18.

Full text

Abstract:

Abstract Treatment strategies for younger patients (<60 years) with AML who enter complete remission (CR) are frequently decided on a risk assessment based on cytogenetic characterisation. Most collaborative groups have devised prognostic cytogenetic groupings of favourable, intermediate or poor risk which have relapse risks of 25–35%, 50–60%, and 80–85% respectively. The precise lesions in each group might vary by study group, but the overall discrimination is consistent. Favourable and possibly intermediate risk cases may not receive transplantation, whereas poor risk cases will. Outcomes

APA, Harvard, Vancouver, ISO, and other styles

49

Nelson, Ariel Ann, Aniko Szabo, and Deepak Kilari. "Impact of cytoreductive nephrectomy (CRN) on overall survival (OS) in metastatic non–clear cell renal cancer (nccRCC)." Journal of Clinical Oncology 41, no. 6_suppl (2023): 730. http://dx.doi.org/10.1200/jco.2023.41.6_suppl.730.

Full text

Abstract:

730 Background: Non-clear cell renal cell carcinoma (nccRCC) accounts for 25% of kidney cancer diagnoses and encompasses a diverse group of kidney tumors with distinct biology for which treatment in the metastatic setting is evolving. The role of CRN for nccRCC population in the current treatment landscape remains unclear. Methods: We retrospectively identified patients (pts) with nccRCC from The National Cancer Database (NCDB) participant user file (PUF) for Kidney and Renal Pelvis Tumors. Pts with de novo metastatic disease diagnosed between 2006 and 2017, received systemic treatment (trt) w

APA, Harvard, Vancouver, ISO, and other styles

50

Berg, Erik. "Afrikas «nye byer»." Plan 53, no. 02 (2021): 42–45. http://dx.doi.org/10.18261/issn.1504-3045-2021-02-11.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!